Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of vaginal misoprostol on post-myomectomy bleeding
IRCT20220101053581N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of misoprostol in Fibromyoma (LM), sponsored by Golestan University of Medical Sciences. Started Apr 2022; status: completed.
02
Drugs
misoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT20220101053581N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220101053581N1.